IL6 and cancer: In our model the overexpression of IκB leads to the inhibition of IL-8 and IL-6 expression which is in line with a previously published report, where the overexpression of a non-degradable IκBα completely abolishes IL-8 production, among other soluble factors, in human epithelial and cancer cell lines [34].